company profile

Portage Biotech (CSE: PTB.U, OTC:PTGEF) is a unique entity in the world of biotechnology, catalyzing R&D to produce more quality clinical programs and maximize potential returns. We do this by leveraging our development strategy and commercial insights, capitalizing on a deep network of industry relationships, and by eliminating typical overhead costs associated with many biotechnology companies. The end result is a viable product development strategy that supports commercial potential and company growth. Our organization is comprised of scientists, clinicians, and pharma experienced executives who have combined their passion for innovation with broad business acumen, to create a better model for product development.

Portage facilitates delivery of the critical foundation that emerging biotechs need; funding, business and clinical counsel, and shared services that enable turnkey execution of commercially-informed development plans. We reduce the risks associated with early clinical development, and have successfully brought ideas to proof-of-concept via efficient capital management and a differentiated approach to scientific oversight, ultimately improving returns 10-30 fold.

market feed

This data does not reflect the real-time price of Portage Biotech shares and is provided as a courtesy. View Portage’s page at the Canadian Securities Exchange.

recent news

reports

corporate presentation